Latently infected CD4+ T cells represent the major barrier to HIV-1 eradication. Many strategies are being developed to eliminate these cells, but the field lacks a simple sensitive assay that can screen for these cells. PCR based assays cannot distinguish between replication-competent versus defective virus and recent studies have shown that the current state of the art culture assay measures only a small fraction of the replication-competent virus present. In this proposal we aim to develop a sensitive assay that is capable of selectively amplifying replication-competent virus from latently infected CD4+ T cells. Such an assay could inform the decision of whether or not to discontinue cART in patients after a therapeutic intervention is made. The need for such an assay is highlighted by the recent report of the 2 Boston patients who were treated with allogeneic stem cell transplantation for malignancies. No HIV DNA was detected by PCR in either patient from as many as 200 million PBMCs (<0.07 copies/106 PBMCs), but after cART was discontinued there was a rapid rebound in viremia in both patients. This outcome is undesirable is it negates the theoretical advantages to having smaller HIV-1 reservoirs. The development of a simple but sensitive assay that can screen a very large number of CD4+ T cells may help prevent the occurrence of a similar scenario from occurring in the future. This work will be important for the development of strategies for HIV-1 eradication since the assay will help inform the decision of whether or not to discontinue antiretroviral therapy.

Public Health Relevance

Latently infected CD4+ T cells represent the major barrier to HIV-1 eradication. A simple but sensitive test is needed to determine whether these cells are still present when patients are subjected to potentially curative procedures. This project plans to determine whether the transfer of PBMC from patients on HAART into immunodeficient mice can be used as an assay that detects the presence of persistent HIV-1 virus.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI120024-03
Application #
9298573
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Mcdonald, David Joseph
Project Start
2015-07-08
Project End
2018-06-30
Budget Start
2017-07-01
Budget End
2018-06-30
Support Year
3
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21205
Ali, Ayub; Ng, Hwee L; Blankson, Joel N et al. (2018) Highly Attenuated Infection With a Vpr-Deleted Molecular Clone of Human Immunodeficiency Virus-1. J Infect Dis 218:1447-1452
Pohlmeyer, Christopher W; Laskey, Sarah B; Beck, Sarah E et al. (2018) Cross-reactive microbial peptides can modulate HIV-specific CD8+ T cell responses. PLoS One 13:e0192098
Veenhuis, Rebecca T; Kwaa, Abena K; Garliss, Caroline C et al. (2018) Long-term remission despite clonal expansion of replication-competent HIV-1 isolates. JCI Insight 3:
Walker-Sperling, Victoria E; Pohlmeyer, Christopher W; Veenhuis, Rebecca T et al. (2017) Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller. EBioMedicine 16:141-149
Henrich, Timothy J; Hatano, Hiroyu; Bacon, Oliver et al. (2017) HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study. PLoS Med 14:e1002417
Kwaa, Abena K; Goldsborough, Kennedy; Walker-Sperling, Victoria E et al. (2017) The effect of Ingenol-B on the suppressive capacity of elite suppressor HIV-specific CD8+ T cells. PLoS One 12:e0174516
Pohlmyer, Christopher W; Bullen, C Korin; Martin, Alyssa R et al. (2017) Characterization of Elite Suppressors Cell-Associated HIV-1 mRNA at Baseline and with T Cell Activation??. Yale J Biol Med 90:331-336
Kuzmichev, Yury V; Veenhuis, Rebecca T; Pohlmeyer, Christopher W et al. (2017) A CD3/CD28 microbead-based HIV-1 viral outgrowth assay. J Virus Erad 3:85-89
Metcalf Pate, Kelly A; Blankson, Joel N (2017) The mouse viral outgrowth assay: avatars for the detection of HIV-1 reservoirs. Retrovirology 14:52
Walker-Sperling, Victoria E; Pohlmeyer, Christopher W; Tarwater, Patrick M et al. (2016) The Effect of Latency Reversal Agents on Primary CD8+ T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication. EBioMedicine 8:217-229